anti-V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A (Avian) (MAFA) Antikörper

Bezeichnung:
anti-V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A (Avian) Antikörper (MAFA)
Auf www.antikoerper-online.de finden Sie aktuell 75 V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A (Avian) (MAFA) Antikörper von 12 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A (Avian) Proteine (6) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 86 V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A (Avian) Produkte verfügbar.
Synonyme:
2F1-Ag, hMafA, L-MAF, MAFA, MAFA-L, mafl, RGD1562627, RIPE3b1, SMaf1

Meistgesuchte Reaktivitäten zu anti-V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A (Avian) (MAFA) Antikörper

Wählen Sie die Spezies und Applikation aus

anti-Mouse (Murine) Antikörper:

anti-Rat (Rattus) Antikörper:

anti-Human Antikörper:

Alle verfügbaren anti-V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A (Avian) Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Am meisten referenzierte anti-V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A (Avian) Antikörper

  1. Human Polyclonal MAFA Primary Antibody für ChIP, GS - ABIN152904 : Wang, Torres-Gonzalez, Tripathy, Botolin, Christian, Jump: Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition. in Journal of lipid research 2008 (PubMed)
    Zeige alle 38 Referenzen für 152904

  2. Human Polyclonal MAFA Primary Antibody für EIA, WB - ABIN953282 : Garin, Martinez, de las Heras, Perez-Nanclares, Castano, Perez de Nanclares: Mutations in MAFA and IAPP are not a common cause of monogenic diabetes. in Diabetic medicine : a journal of the British Diabetic Association 2009 (PubMed)
    Zeige alle 5 Referenzen für 953282

  3. Human Polyclonal MAFA Primary Antibody für EIA, WB - ABIN953280 : Lecoin, Rocques, El-Yakoubi, Ben Achour, Larcher, Pouponnot, Eychène: MafA transcription factor identifies the early ret-expressing sensory neurons. in Developmental neurobiology 2010 (PubMed)
    Zeige alle 4 Referenzen für 953280

  4. Human Polyclonal MAFA Primary Antibody für EIA, WB - ABIN953281 : Martin, Flemming, Wang, Oeser, OBrien: Foxa2 and MafA regulate islet-specific glucose-6-phosphatase catalytic subunit-related protein gene expression. in Journal of molecular endocrinology 2008 (PubMed)
    Zeige alle 3 Referenzen für 953281

  5. Dog (Canine) Polyclonal MAFA Primary Antibody für WB - ABIN2783128 : Matsuoka, Kaneto, Stein, Miyatsuka, Kawamori, Henderson, Kojima, Matsuhisa, Hori, Yamasaki: MafA regulates expression of genes important to islet beta-cell function. in Molecular endocrinology (Baltimore, Md.) 2007 (PubMed)

  6. Human Polyclonal MAFA Primary Antibody für WB - ABIN653392 : Kondo, El Khattabi, Nishimura, Laybutt, Geraldes, Shah, King, Bonner-Weir, Weir, Sharma: p38 MAPK is a major regulator of MafA protein stability under oxidative stress. in Molecular endocrinology (Baltimore, Md.) 2009 (PubMed)

Weitere Antikörper gegen V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A (Avian) Interaktionspartner

Mouse (Murine) V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A (Avian) (MAFA) Interaktionspartner

  1. Treg cell accumulation in intestinal tumours from APC (zeige APC Antikörper)(min/+) mice was exclusively due to the increase in KLRG1 (zeige KLRG1 Antikörper)(+) GATA3 (zeige GATA3 Antikörper)(+) Treg cells.

  2. Although absence of KLRG1 (zeige KLRG1 Antikörper) is not enough to increase intestinal Treg cells in KLRG1 (zeige KLRG1 Antikörper) knockout mice, KLRG1 (zeige KLRG1 Antikörper) ligation reduces T-cell receptor signals and the competitive fitness of individual Treg cells in the intestine.

  3. Mafa was found to both potentiate the ability of Pdx1 (zeige PDX1 Antikörper) to induce beta-cell formation from Ngn3 (zeige NEUROG3 Antikörper)-positive endocrine precursors and enable Pdx1 (zeige PDX1 Antikörper) to produce beta-cells from alpha-cells.

  4. Ly6C, 4-1BB (zeige TNFRSF9 Antikörper), and KLRG1 (zeige KLRG1 Antikörper) have roles in the activation of lamina propria lymphocytes in the small intestine in a mouse model of Crohn's disease

  5. MAFA controls autonomic nervous system-mediated insulin secretion by activating the transcription of nicotinic (ChrnB2 and ChrnB4) receptor genes, which is impaired in type 2 diabetes.

  6. These findings demonstrate that regulation of monoamine levels by Mao (zeige MAO Antikörper) activity in beta cells is pivotal for physiological insulin (zeige INS Antikörper) secretion and that loss of MaoB (zeige MAOB Antikörper) expression may contribute to the beta cell dysfunction in type 2 diabetes.

  7. is necessary for the maintenance of normal insulin (zeige INS Antikörper) levels even in embryos.

  8. endogenous small-Maf (zeige MAF Antikörper) factors negatively regulate beta-cell function by competing for MafA binding, and thus, the inhibition of small-Maf (zeige MAF Antikörper) activity can improve beta-cell function

  9. Data, including data from studies using transgenic/knockout mice, confirm the expression of Mafa and Mafb (zeige MAFB Antikörper) is specific to insulin (zeige INS Antikörper)-secreting cells of the pancreas.

  10. These results suggest that MafA regulates the postnatal proliferation of beta-cells via prolactin (zeige PRL Antikörper) signaling.

Human V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A (Avian) (MAFA) Interaktionspartner

  1. Pdx1 (zeige PDX1 Antikörper) and MafA (zeige KLRG1 Antikörper) play crucial roles in the pancreas and maintain mature beta-cell function. Our results showed that the expression of Pdx1 (zeige PDX1 Antikörper) and MafA (zeige KLRG1 Antikörper) were significantly upregulated after a sleeve gastrectomy for morbid obesity.

  2. MAFA controls autonomic nervous system-mediated insulin secretion by activating the transcription of nicotinic (ChrnB2 and ChrnB4) receptor genes, which is impaired in patients with type 2 diabetes.

  3. These findings demonstrate that regulation of monoamine levels by Mao (zeige MAO Antikörper) activity in beta cells is pivotal for physiological insulin (zeige INS Antikörper) secretion and that loss of MaoB (zeige MAOB Antikörper) expression may contribute to the beta cell dysfunction in type 2 diabetes.

  4. MAFA (zeige KLRG1 Antikörper), MAFB (zeige MAFB Antikörper), NKX6.1 (zeige NKX6-1 Antikörper), and PDX1 (zeige PDX1 Antikörper) activity provides a gauge of islet beta cell function, with loss of MAFA (zeige KLRG1 Antikörper) (and/or MAFB (zeige MAFB Antikörper)) representing an early indicator of beta cell inactivity

  5. Loss of MAFA (zeige KLRG1 Antikörper) expression is associated with insulinoma (zeige RPS15 Antikörper).

  6. MAFA (zeige KLRG1 Antikörper) nuclear expression in pancreatic alpha and beta cells, and the percentage of alpha cells expressing PAX4 (zeige PAX4 Antikörper) are altered in patients with type 2 diabetes.

  7. under oxidative and nonoxidative conditions p38 MAPK (zeige MAPK14 Antikörper) directly binds to MafA (zeige KLRG1 Antikörper) and triggers MafA (zeige KLRG1 Antikörper) degradation via ubiquitin proteasomal pathway.

  8. Beta cell nuclear MafA (zeige KLRG1 Antikörper) is markedly decreased in humans with type 2 diabetes, which may contribute to impaired beta cell dysfunction.

  9. Combined transfection of the three transcriptional factors, PDX-1 (zeige PDX1 Antikörper), NeuroD1 (zeige NEUROD1 Antikörper), and MafA (zeige KLRG1 Antikörper), causes differentiation of bone marrow mesenchymal stem cells into insulin (zeige INS Antikörper)-producing cells

  10. Data suggest that MafA (zeige KLRG1 Antikörper) plays a novel role in the reprogramming of stem cells into pancreatic beta-progenitors, promotes the islet-like characteristics of PDMSCs, as well as functionally regulation of blood glucose levels in transplanted grafts.

V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A (Avian) (MAFA) Antigen-Profil

Beschreibung des Gens

MAFA is a transcription factor that binds RIPE3b, a conserved enhancer element that regulates pancreatic beta cell-specific expression of the insulin gene (INS\; MIM 176730) (Olbrot et al., 2002

Alternative names and synonyms associated with V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A (Avian) (MAFA)

  • killer cell lectin-like receptor subfamily G, member 1 (Klrg1) Antikörper
  • v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (mafa) Antikörper
  • v-maf avian musculoaponeurotic fibrosarcoma oncogene A (Mafa) Antikörper
  • v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog A (MAFA) Antikörper
  • v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A (avian) (Mafa) Antikörper
  • v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (MAFA) Antikörper
  • v-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian) (mafa) Antikörper
  • 2F1-Ag Antikörper
  • hMafA Antikörper
  • L-MAF Antikörper
  • MAFA Antikörper
  • MAFA-L Antikörper
  • mafl Antikörper
  • RGD1562627 Antikörper
  • RIPE3b1 Antikörper
  • SMaf1 Antikörper

Bezeichner auf Proteinebene für MAFA

killer cell lectin-like receptor subfamily G member 1 , mast cell function-associated antigen 2F1 , mast cell function-associated antigen , v-maf musculoaponeurotic fibrosarcoma oncogene homolog A , Transcription factor MafA , leucine zipper transcription factor , v-maf musculoaponeurotic fibrosarcoma oncogene family, protein A , pancreatic beta-cell-specific transcriptional activator , transcription factor MafA , transcription factor RIPE3b1 , Mafa homolog , V-maf musculoaponeurotic fibrosarcoma oncogene homolog A , bZIP transcription factor L-Maf , lens-specific Maf , somite Maf1 , v-maf musculoaponeurotic fibrosarcoma oncogene family, protein L

GENE ID SPEZIES
50928 Mus musculus
58975 Rattus norvegicus
613050 Xenopus (Silurana) tropicalis
366949 Rattus norvegicus
389692 Homo sapiens
378435 Mus musculus
395881 Gallus gallus
100000492 Danio rerio
Ausgewählte Anbieter für anti-V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A (Avian) (MAFA) Antikörper
Haben Sie etwas anderes gesucht?